Login
| TI Ref No : | 531704101 |
|---|---|
| Description : | Successful Delivery Of A Medicinal Product Containing The Active Substance Nivolumab As Part Of A Non-commercial Clinical Trial: "efficacy And Tolerability Of N-avd Compared To Brecadd In Patients With Advanced Hodgkin Lymphoma (n-brave)" |
| Date : | 2026-04-17 |
| Deadline : | 2026-05-18 |
| Document Type : | Tenders |
